Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Blue Jays Rumors

Blue Jays Release Tim Mayza

By | at

The Blue Jays have released Tim Mayza, according to the left-hander’s player page on MLB.com. He was designated for assignment last week.

This marks the end, at least for now, of Mayza’s 11-year career with Toronto. The Blue Jays selected him in the 2013 draft, and he made his MLB debut at the Rogers Centre four years later. He would go on to make 352 appearances over the next eight years, far more than any other pitcher on the team in that span; he ranks eighth all-time in appearances by a Blue Jays pitcher.

Mayza became a key player in Toronto’s bullpen in 2021, and over the next three years, he pitched 155 innings with a 2.67 ERA. The southpaw had the best season of his career just last year, pitching to a 1.52 ERA in 69 games. His underlying stats were not quite as impressive, but his 3.11 SIERA and 3.38 xERA were still good numbers, especially for a higher-leverage reliever like Mayza. Thus, his struggles in 2024 came as a major surprise.

In 24 2/3 innings over 35 games this year, Mayza gave up 24 runs (22 earned) on 36 hits and 12 walks. He managed to strike out only 16 of the 121 batters he faced. All of that added up to an 8.03 ERA, which makes him the only reliever in the league (min. 20 IP) with an ERA over 8.00. While his underlying numbers are better than his ERA, they’re still disappointing across the board. His 5.04 SIERA and 6.77 xERA both rank last among Blue Jays relievers (min. 10 IP), which is especially bad considering the Blue Jays have had one of the least effective bullpens in baseball this season. With all that in mind, the team’s decision to release Mayza is not difficult to understand – even though it would have been almost impossible to imagine at the beginning of the year.

After more than a decade with the Blue Jays, Mayza will now be able to seek employment elsewhere. At 32 years old, he could be an intriguing reclamation project for an organization that thinks it can help him regain his 2023 form.

Jordan Romano Shut Down For Six Weeks Following Arthroscopic Elbow Surgery

By | at

Blue Jays right-hander Jordan Romano underwent arthroscopic surgery today to repair an impingement in his throwing elbow. Manager John Schneider relayed the news to the club’s beat, with Keegan Matheson of MLB.com among those to relay the news on X. The closer will be shut down from throwing for at least six weeks, with his potential return this season dependant on how things progress from that point.

Romano’s elbow has been an issue all year long. The 31-year-old was shut down during Spring Training due to some inflammation and began the season on the 15-day injured list. He was able to come off the IL by mid-April but struggled, with a 6.59 earned run average in 15 appearances. He was placed back on the IL at the start of June, again due to inflammation in that elbow. He seemed to be on the road to rejoining the club last month but was shut down due to some more soreness about two weeks ago.

On the weekend, there was an ominous update. Schneider told reporters that Romano was going to visit Dr. Keith Meister, who has been a key figure in developing the internal brace/Tommy John surgery hybrid.

Relative to the worst-case scenario evoked by that doctor visit, today’s update counts as good news. A Tommy John surgery comes with a timeline of more than a year, which would have definitely ended Romano’s 2024 and even made it difficult for him to pitch next year.

This procedure’s six-week no-throw timeline is far better than that but still not great for Romano or the Jays. Once he starts throwing again, it will be the middle of August and he will have to ramp things back up from there, which is why it’s still questionable whether he can return this season at all.

The Jays are currently 39-46 and on the fringes of contention, currently seven games back of a playoff spot. A disappointing bullpen has been a big part of their struggles, as the club’s relievers had a collective 3.68 ERA last year, a top ten mark in the majors. This year, the relief corps has a 4.73 ERA, better than just the Angels and Rockies. That’s been partly due to Romano, but also pitchers like Erik Swanson and Tim Mayza have struggled and Yimi García has been on the injured list for a while.

The Jays will have to make some tough decisions in the coming weeks about whether they are buyers or sellers, and the loss of Romano will be hurtful on either path. Over the 2021 to 2023 seasons, he racked up 95 saves, trailing only Emmanuel Clase, Kenley Jansen and Josh Hader. He had a 2.37 ERA, 30.3% strikeout rate and 9.2% walk rate in that stretch.

Getting Romano healthy and back in that form could have played a role in getting them back in the playoff race. Conversely, if the club eventually takes the seller path, Romano would have been an attractive trade candidate. He is making $7.75MM this year and has one year of arbitration control remaining. Now that he’s potentially out for the year, he won’t be able to help the Jays steady the ship nor will he be able to bring back young talent in a deadline deal. Players on the IL can be traded but the offers would surely be unpalatable to the Jays right now, given Romano’s current health status.

If the Jays can stay in the playoff race for the next few months, perhaps the return of Romano will be a key storyline to watch, as he could serve as a fresh arm in September and/or October. Or if the club is out of it, the club would surely like to see him back on the mound before deciding whether or not to tender him a contract for next year.

He won’t be able to command a huge arbitration raise since his work this year has been so limited and also ineffective. Having Romano back to genuine closer status at around $8MM for one year would still be a huge bargain, though if the elbow issues linger and there’s a chance of him missing any of 2025, that would obviously change the calculus there.

Blue Jays Place Isiah Kiner-Falefa On Injured List, Recall Leo Jimenez For Major League Debut

By | at

The Blue Jays announced that infielder Isiah Kiner-Falefa has been placed on the 10-day injured list with a left knee sprain. Infielder Leo Jimenez has been recalled in a corresponding move and will be making his major league debut as soon as he gets into a game.

Kiner-Falefa, 29, was a late scratch from yesterday’s game. Manager John Schneider said that the infielder “felt something” which “popped up out of nowhere” during his pre-game stretches, per Hazel Mae of Sportsnet on X. It’s unclear how much time the Jays expect him to miss but the injury is significant enough that he’ll require an IL stint.

Signed to a two-year deal in the offseason, IKF has been having the best campaign of his career thus far. He has always been a glove-first utility guy but had hit just .261/.314/.346 coming into the year for an 81 wRC+. Though much has gone wrong for the Jays here in 2024, Kiner-Falefa’s deal has been a nice development, as he has hit .292/.338/.420 for a wRC+ of 117. He’s done that while playing the three infield positions to the left of first base and one inning in center field as well. His 2.0 wins above replacement are currently leading the team, according to the calculations at FanGraphs.

It’s a less than ideal development for the Jays, who have fallen back in the American League playoff picture. Though many contenders have been bunched up in the Wild Card race for a lot of the year, the Jays have slipped to 38-46, tied with the Tigers and Rangers and eight games out of the last postseason spot. With the trade deadline less than a month away, the club will need a serious hot streak to avoid a summer selloff, which will be harder to do without one of their more productive players on the season. If the summer selloff does end up coming to pass, there would also be an argument for selling high on IKF, though that could perhaps be less likely now, depending on how things develop in the next few weeks.

In the meantime, Jimenez gets his first call to the big leagues. An international signing out of Panama in 2017, he’s long been considered one of the better prospects in the Jays’ system. Baseball America has ranked him one of the top 30 farmhands in the organization since 2019, generally considering him a strong defender at shortstop but with a possibility that he ends up at second base due to his arm.

Offensively, Jimenez is considered more of a line drive hitter than a power threat but the plate discipline appears to be strong. He has stepped to the plate just under 1200 times since the start of 2021 with just 22 home runs but a 12.8% walk rate and a 16.4% strikeout rate. He’s slashed a combined .269/.404/.401 in that time for a wRC+ of 127. That includes a line of .271/.416/.431 and 129 wRC+ in 57 Triple-A games this year, with a 13.3% walk rate and 15% strikeout rate.

Jimenez has mostly played shortstop this year but also some second base. The Jays have Bo Bichette at short but the keystone could be available. Vladimir Guerrero Jr. has some sore fingers after being hit by a pitch and missed yesterday’s game, so Spencer Horwitz could perhaps move to first until Guerrero is ready to return. That would leave second base open for Jimenez and Davis Schneider, though Schneider has also been playing left field this year.

Though this is his first call to the big leagues, Jimenez was actually added to the 40-man roster back in November of 2021 to keep him out of the Rule 5 draft. That means he is in his final option year and will be out of options by next season. Given his solid profile, he’ll likely be ticketed for a role on next year’s team. If the 2024 season ends up being a lost year for the Jays, they can at least use the final months of the schedule to audition controllable players like Jimenez, Horwitz, Schneider and Addison Barger as they evaluate how to approach building next year’s roster.

Blue Jays Acquire Yerry Rodriguez

By | at

The Rangers and Blue Jays have completed a trade, as both clubs announced that right-hander Yerry Rodriguez is heading to Toronto in exchange for minor league righty Josh Mollerus.  Rodriguez has been optioned to Triple-A Buffalo, while the Rangers assigned Mollerus to their high-A affiliate.

Texas designated Rodriguez for assignment earlier this week, and today’s trade officially ends Rodriguez’s decade-long run in the Rangers organization.  An international signing out of the Dominican Republic in September 2015, Rodriguez made his MLB debut in 2022 and has a 7.11 ERA over 31 2/3 big league innings for the Rangers over the last three seasons.  This year in particular, Rodriguez has a 6.88 ERA in 17 frames, allowing five homers and recording almost as many walks (11) as strikeouts (12).

Almost something of a control specialist during his earliest days as a prospect, Rodriguez’s walk rates have become increasingly problematic over three-plus years at the Triple-A level.  The righty has a 5.42 ERA in 151 career Triple-A innings, and his walk rate spiked up to 15.2% this season over 13 1/3 frames at Round Rock.

On the plus side, Rodriguez is a hard thrower who has a 28.16% strikeout rate in his Triple-A career.  While this swing-and-miss ability hasn’t translated yet to Rodriguez’s big league work (18.9K% in the majors), Rodriguez has stuff to appeal to other teams, and Toronto scouts may have seen something to make them think they can fix Rodriguez’s control problems.

If nothing else, the trade adds an MLB-ready reliever to the depth chart of a Blue Jays team in sore need of bullpen help.  Between the number of injuries and ineffective arms in the Jays relief corps, Rodriguez is an optionable reliever who can shuttled up and down from Triple-A a few more times when the Blue Jays are in need of a fresh arm.  A starter earlier in his career, Rodriguez has mostly transitioned over to full-time relief work, and can operate as a multi-inning reliever.

Mollerus is a University of Oregon product who was a 10th-round pick for Toronto in last year’s draft.  Mollerus’ early results have also yielded a high number of strikeouts and walks, as the right-hander has a 32.26% strikeout rate and a 15.05% walk rate over 42 1/3 pro innings.  Starting at A-level Dunedin last season, Mollerus has pitched with high-A Vancouver in 2024.

Jordan Romano To Receive Evaluation After Continued Elbow Discomfort

By | at

Blue Jays closer Jordan Romano is set to visit Dr. Keith Meister on July 2, manager John Schneider told reporters (including the Athletic’s Kaitlyn McGrath and Sportsnet’s Shi Davidi).  Romano has been on the injured list due to right elbow inflammation for almost a month, and his throwing work has now been halted for a second time due to continued soreness.  Some soreness last week led to a pause for a few days, but Romano has now been shut down from throwing entirely after a throwing session yesterday.

While Schneider noted that no structural damage has been found in other examinations of Romano’s elbow to date, it is naturally a little ominous to hear that any pitcher is visiting Dr. Meister.  It was just earlier this month that Meister performed a UCL surgery on another prominent Blue Jays pitcher in Alek Manoah, and a similar procedure represents the worst-case scenario for Romano if his recurring elbow problem is due to more than just inflammation.  Romano would miss at least the next year of action recovering from an internal brace procedure (one of Meister’s specialties) or the standard Tommy John surgery would likely keep him out of action until Opening Day 2026.

Today’s news is the latest twist in what is increasingly looking like it might be a lost season for Romano, who has a 6.59 ERA over 13 2/3 innings and 15 appearances.  These underwhelming numbers came in between both his current IL stint and another season-opening IL stint also due to elbow inflammation, as Romano didn’t pitch in his first game until April 16.

Romano has been Toronto’s closer for the last three seasons, posting a sterling 2.37 ERA over 186 innings while recording 95 saves in 106 chances.  While Romano could be homer-prone and his 9.2% walk rate was nothing special, his 30.3% strikeout rate was powered by a strong one-two punch of a fastball/slider combination, helping him receive All-Star nods in both 2022 and 2023.

More will be known after Romano’s consultation on Tuesday, but an extended absence could potentially bring his tenure with the Jays to an end.  Romano is under arbitration control through the 2025 season, though if his 2025 campaign is now in jeopardy altogether, the Blue Jays could consider not even tendering him a contract this winter.  Perhaps more likely, the Jays might explore a two-year extension with Romano, locking him up for both 2025 and what would hopefully be a fully healthy 2026 season.

Even if the elbow problem proves to be relatively minor, it almost surely means that Romano will still be a Blue Jays beyond the July 30 deadline, as it doesn’t seem likely he’ll be back on a big league mound in a month’s time.  A healthy Romano might have been a prime deadline trade chip for a Jays team that looking to be falling out of contention, though obviously having a healthy and effective Romano in 2024 could’ve greatly altered Toronto’s fortunes.  With Romano, Yimi Garcia, Erik Swanson, and Tim Mayza all waylaid by injuries and/or ineffectiveness, the Jays’ relief corps has a 4.78 ERA, ranking third-worst in all of baseball.

Blue Jays Designate Tim Mayza For Assignment

By | at

The Blue Jays announced that left-hander Tim Mayza has been designated for assignment.  Righty Jose Cuas (just claimed off waivers from the Cubs last week) has been called up from Triple-A Buffalo to take Mayza’s spot on the active roster.

Today’s news likely ends Mayza’s tenure with the Jays, which began when he was a 12th-round pick for the club in the 2013 draft.  (Danny Jansen was a 16th-round pick in that same draft and is now officially Toronto’s longest-tenured player.)  Designating Mayza would’ve seemed inconceivable just a few months ago, as Mayza was quietly one of baseball’s better relievers in 2023, posting a 1.52 ERA over 53 1/3 frames.  A 3.11 SIERA was a little less flattering, but Mayza still had solidly above-average walk and strikeout rates, as well as elite grounder (58.2%) and barrel (4.1%) rates.  Mayza allowed only two homers over his 53 1/3 innings, as while he allowed a fair amount of hard contract overall, his ability to keep the ball in the park greatly limited the damage.

However, the dropoff has been as sharp as it was unexpected.  Mayza has already allowed three home runs in 24 2/3 innings this season, contributing to a garish 8.03 ERA.  The Statcast numbers reveal a slew of below-average metrics, including a 13.2% strikeout rate that is among the worst in the league, and a 39.1% grounder rate that is far below the 54.4% career average that Mayza carried into 2024.  A .367 BABIP has partially contributed to Mayza’s problems, though while his 5.03 SIERA is three runs lower than his ERA, it is clear that Mayza’s struggles are due to far more than just bad batted-ball luck.

Things reached a low point in Mayza’s last two outings, as he faced eight batters and allowed seven earned runs without recording even a single out.  These two disastrous performances (against the Red Sox last Monday and against the Yankees last night) raised his ERA from 5.47 to 8.03, and essentially might have forced the Blue Jays’ hand in making a tough call on a veteran reliever.

Starting the season with four years and 156 days of MLB service time, Mayza needed just 16 more days on the big league roster to hit the five-year threshold, so he is now far beyond that mark.  Five years of service time gives Mayza the right to refuse a minor league assignment, and though he has two minor league options remaining, it could be that Mayza exercised his right to pass on a trip to Triple-A Buffalo.

In deciding to DFA Mayza, Toronto has now left open the possibility that he could leave the organization altogether via waiver claim.  A claiming club would have to cover the roughly $1.7MM remaining of Mayza’s remaining salary, and since the Jays would be eating that money in the event of a release, it is possible teams might choose to see if Mayza indeed hits the open market in order to save some cash.  That said, Mayza’s salary isn’t particularly onerous, so any number of teams with bullpen needs might very well be looking to put in a claim or to work out a trade with the Blue Jays during the DFA period.  As rough as Mayza’s performance has been in 2024, he could be an interesting change-of-scenery candidate, given his stronger career track record.

After a Tommy John surgery cost him the entire 2020 season, Mayza returned to post a 2.67 ERA over 155 relief innings from 2021-23, along with a 24.9% strikeout rate, 6.3% walk rate, and 58.3% groundball rate.  He has naturally been a lot better against left-handed batters than right-handed batters over his career, and even amidst his struggles this year, Mayza has held lefty swingers to a .280/.362/.360 slash line in 58 PA.  The batting average and OBP leave something to be desired, but at least this version of Mayza can still limit the power of left-handed hitters.

Since Mayza is also a Super Two player, he has another year of arbitration eligibility before hitting free agency following the 2025 season.  If Mayza joins another team and gets back to his old form, he suddenly becomes an inexpensive piece for a club’s roster next season as well.

Blue Jays relievers have a collective 4.78 ERA this season, ranking 28th of the 30 Major League bullpens.  Injuries to Jordan Romano and Yimi Garcia haven’t helped matters, but Romano was struggling even when not on the injured list, and both Mayza and Erik Swanson (who has been optioned to Triple-A) saw their production crater after impressive 2023 seasons.

Between the leaky bullpen, the inconsistent offense, and a starting rotation that pretty average across the board, not much as gone right for the Blue Jays as they have stumbled to a 37-44 record.  The Jays already parted ways with another struggling homegrown player in Cavan Biggio earlier this month when Biggio was traded to the Dodgers, and if Mayza is also traded or claimed away on waivers, the moves essentially act as harbingers that Toronto will be selling at the deadline.  GM Ross Atkins said two days ago that the Jays are still “focused on building the best possible team we can this year,” but “if we get to a point where we need to adjust, we’ll be prepared to do so.“

Blue Jays’ GM Ross Atkins Talks Deadline Approach

By | at

Even after last night’s 9-2 drubbing of the Yankees, the Blue Jays sit six games below .500. They’re at the bottom of the AL East with a 37-43 record and have three teams between them and the Royals — the current holder of the American League’s final playoff spot.

It’s certainly not where the Jays expected to find themselves at the season’s halfway point. Toronto had won between 89 and 92 games in each of the past three seasons and has gotten to the postseason in three of the last four years. They should be squarely in their competitive window.

That sets the Jays up as one of the more interesting pivot teams over the next month. They’re not eager to sell, but they’re running low on time to play their way back into the playoff mix. Toronto is 6.5 back in the Wild Card race. Any hope they had of winning the division coming into this year has long since disappeared.

GM Ross Atkins acknowledged the team’s precarious position when he spoke with the Toronto beat before Thursday’s win. “We’ve obviously put ourselves into a tough spot over the last seven days,” Atkins said (link via Keegan Matheson of MLB.com). “Ten days ago, we were feeling like there was positive momentum, and that has gone away.”

Jeff Passan of ESPN wrote earlier this week that the Jays weren’t yet willing to make key players available in trade. Atkins suggested similarly in his comments on Thursday, saying the front office’s “focus is on the 2024 team.” While the GM acknowledged that any decision also involves consideration of the future, he pointed to the organization’s investment in both payroll and prospect capital in this roster. “We’ll continue to do that until it doesn’t make sense to do so any more,” he added.

That naturally raises the question of when the front office could decide they have no choice but to turn their focus toward the future. That’ll largely depend on how things play out in the next four to five weeks — both in Toronto and around the rest of the American League. “The coming days are exceptionally important to us, and understanding the market is also exceptionally important to us in either way,” Atkins said (via Matheson). “We’re focused on winning. We’re focused on building the best possible team we can this year and supporting them the best we can. If we get to a point where we need to adjust, we’ll be prepared to do so.”

Toronto isn’t unique in that regard. There are only five or six (depending on one feels about the Tigers) teams who look like clear-cut sellers at this point. Yet there aren’t many more who can feel secure about their chances of getting to the postseason. Upwards of half the teams in the league could decide their deadline direction based on how they perform in July. Various clubs could also try to straddle the line by offloading some veterans while looking for immediate help in other areas of the roster.

The Jays have a more established roster than most of those fringe teams. Toronto has potentially impactful trade candidates with varying levels of club control. Neither Danny Jansen nor Yusei Kikuchi has played well in recent weeks, yet they’d both started the season quite well. Jansen is the top impending free agent catcher, while Kikuchi would be one of the more talented rental starting pitchers on the market if the Jays made him available.

Yimi García is pitching well and would be a straightforward target for teams seeking veteran bullpen help if he’s healthy by the deadline.  (He went on the injured list with elbow neuritis two weeks ago.) Justin Turner and Kevin Kiermaier are having disappointing seasons. While the Jays would probably have to kick in cash to facilitate trades of either player, they could get calls based on their pre-2024 track records.

Things would become more interesting if the Jays seriously considered moving key players who are under control beyond this season. That would signify a bigger reset than merely trading rentals. There’s an argument for doing so if the Jays can’t claw back into contention over the next few weeks. Toronto has a handful of players who are in or at the back end of their primes. They’ve got dwindling control windows on franchise faces Vladimir Guerrero Jr. and Bo Bichette, each of whom are slated for free agency after the 2025 campaign. Bichette will make $16.5MM next season, while Guerrero is going to be due a noteworthy raise on this year’s $19.9MM salary.

Atkins bluntly shot down the notion of trading either star hitter earlier this month. That presumably won’t stop teams from calling to gauge whether the Jays are willing to reconsider. Bichette himself told Hazel Mae (X link) that he wouldn’t be surprised if the Jays moved him, though that’d presumably change if the team plays its way back into contention.

Guerrero is amidst arguably the second-best offensive season of his career. He’s hitting .289/.370/.447 across 351 plate appearances. While he hasn’t hit for the same level of power he did in 2021-22, Guerrero has the second-highest average and on-base mark of his career. Bichette hasn’t performed to his usual standard, running a personal-worst .232/.282/.333 slash line over 287 trips. While that’d arguably make this summer an inopportune time to move him, Bichette would surely still draw ample attention if the Jays put him on the market. There aren’t many everyday shortstops who seem likely to be available.

Beyond that duo, the Jays have a handful of controllable players who could generate calls, particularly on the pitching side. Jordan Romano has spent the past month on the injured list with elbow inflammation. He’s a two-time All-Star closer who is under arbitration control through next season, though. Romano recently resumed throwing from 120 feet on flat ground (via the MLB.com injury tracker). Chris Bassitt is making $22MM this season and next. He turned in a 3.60 ERA over 33 starts a year ago and has worked to a 3.45 mark with decent strikeout and walk numbers over 91 1/3 innings. Trading Kevin Gausman, who is under contract through 2026, still seems unlikely unless the front office kicks off a more significant reboot.

If the Jays perform the way they’re hoping over the next month, adding to the bullpen and deepening the lineup would be the likely priorities. The Romano and García injuries — paired with Erik Swanson’s struggles — have contributed to the Jays running out one of the least consistent relief groups in the majors. The bottom half of the lineup hasn’t performed up to expectations either. That’s largely due to underperformance from the likes of Bichette, Turner, Kiermaier and George Springer. The Jays also entered the season with questions at second and third base. They’ve plugged rookie Spencer Horwitz into regular action at the keystone while free agent signee Isiah Kiner-Falefa (who has somewhat quietly impressed with a .283/.333/.402 showing) has gotten the bulk of the third base reps.

MLBTR Podcast: Injured Trade Candidates, The Cristopher Sánchez Extension And Blue Jays’ Woes

By | at

The latest episode of the MLB Trade Rumors Podcast is now live on Spotify, Apple Podcasts, and wherever you get your podcasts! Make sure you subscribe as well! You can also use the player at this link to listen, if you don’t use Spotify or Apple for podcasts.

This week, host Darragh McDonald is joined by Steve Adams of MLB Trade Rumors to discuss…

Plus, we answer your questions, including…

  • “What would it take for the Rockies to consider trading some young assets like Ryan McMahon or Brendan Rodgers?” (23:55)
  • “The Astros are clearly out of it, so why isn’t Ryan Pressly a top target of teams with bad bullpens?” (30:35)
  • “Would the Marlins or Nationals trade with the Mets, Phillies or Braves, with Jazz Chisholm Jr. and Lane Thomas being good fits?” (39:25)
  • “Will T.J. McFarland of the Athletics be traded to the Cubs or another contender?” (47:45)

Check out our past episodes!

The podcast intro and outro song “So Long” is provided courtesy of the band Showoff.  Check out their Facebook page here!

Blue Jays Claim Jose Cuas Off Waivers From Cubs

By | at

The Cubs announced this afternoon that right-hander Jose Cuas has been claimed off waivers by the Blue Jays. Cuas was designated for assignment earlier this week in order to make room for righty Ethan Roberts on the club’s 40-man roster. The move puts Toronto’s 40-man roster at capacity.

Cuas, who will celebrate his 30th birthday later this week, made his big league debut with the Royals back in 2022 but was traded to the Cubs in exchange for outfielder Nelson Velazquez at the trade deadline last summer. He was a decent middle reliever for the Royals during his time in Kansas City, pitching to a 4.08 ERA (106 ERA+) with a 4.41 FIP in 79 1/3 innings of work for the club between the 2022 and ’23 campaigns. Unfortunately for both Cuas and the Cubs, the wheels began to come off for the sidearming righty upon his arrival in Chicago last year.

While his 3.04 ERA in 27 appearances for the Cubs down the stretch last summer was actually fairly strong, it came with concerning peripherals. His strikeout rate dipped from a strong 27.1% during his time with the Royals last year to a worrisome 19% in Chicago, while his walk rate simultaneously ballooned from a manageable 10% figure in Kansas City all the way up to 14% for the north siders. While a strong 55.6% groundball rate allowed Cuas to keep the damage to a minimum, he was no longer looking the part of a quality middle relief option.

Things took an even worse turn for Cuas in 2024 when his groundball rate plummeted to just 31%. While his walk rate dropped down to a career-best 9.2% figure, that came at least in part as a result of opposing hitters teeing off Cuas pitches with a 14.3% barrel rate and a 45.2% Hard Hit rate. While Cuas’s strikeout rate crept back up to a more acceptable 21.5% this year, that still wasn’t enough to stop the right-hander from surrendering 12 runs (11 earned) in 13 1/3 innings of work for the Cubs this year, leaving him with a 7.43 ERA and a 5.99 FIP.

Despite those deep struggles during his time in Chicago, it’s not hard to see why the Blue Jays would want to take a chance on the righty. After all, when Cuas’s arsenal is working well, his sinker/slider combo allows him to strike out around a quarter of the batters he faces while keeping walks to a clip of around 10% and eliciting grounders on around half of his batted balls. That’s certainly the profile of a valuable pitcher, even though Cuas has not been able to put it all together at the big league level yet during his career.

Even if he isn’t able to reach that potential, the right-hander still provides the Blue Jays with an optionable relief arm on a minimum salary who can be shuttled from Triple-A to the majors as necessary. That’s a valuable commodity for any bullpen, but especially for a Blue Jays bullpen that has posted a league-worst 4.83 FIP to this point in the 2024 campaign. Should the club turn to Cuas at some point, he’d likely factor into the middle relief mix alongside the likes of Zach Pop and Genesis Cabrera.

Orelvis Martinez Receives 80-Game Suspension Following Positive PED Test

By | at

The MLB commissioner’s office announced this morning that Blue Jays infielder Orelvis Martinez has received an 80-game suspension without pay after testing positive for Clomiphene, a banned performance enhancing substance. The suspension is effective immediately. Martinez has since been placed on the restricted list, and the Blue Jays have selected the contract of outfielder Steward Berroa to replace the infielder on the active and 40-man rosters.

“The Blue Jays fully support Major League Baseball’s Joint Drug Prevention and Treatment Program, and strongly believe in keeping the game on a level playing field,” Blue Jays GM Ross Atkins said in a statement this morning. “We were both surprised and disappointed to hear of Orelvis Martinez’s suspension. We will do everything in our power to ensure Orelvis has learned from this mistake. Orelvis has our support, and we know he will get through this.”

Martinez released a statement of his own via the MLB Players Association:

“For the past two years, I have been trying to start a family with my girlfriend. During the offseason, we visited a fertility clinic in the Dominican Republic and after getting lab work done, we were prescribed a treatment, which included a medication called Rejun 50. Unfortunately, Rejun 50 contains a banned substance called Clomiphene.

We wanted to keep this matter private, even within our family, and trusted the doctor who assured us this treatment did not include performance enhancing drugs. Therefore, I made the mistake of not disclosing this to my team or the MLBPA. With that said, I took full responsibility for my actions and accepted my suspension.

I want to apologize to my teammates in both Buffalo and Toronto, the Blue Jays organization, and most importantly, the fans who have supported me during my career. I will learn from this experience and come back to the field in September.”

The news is a major blow to the Blue Jays, who recalled Martinez for his big league debut just this past week to join the club’s infield mix after shortstop Bo Bichette hit the injured list with a calf strain. Martinez has just one game under his belt in the majors so far, having gone 1-for-3 with a strikeout while playing second base in his big league debut on Friday. While Martinez’s big league career had only just begun, he’s long been considered a consensus top-100 prospect in the sport and was in the midst of an excellent showing at Triple-A this year when he received the call to the majors. In 63 games for the club’s Buffalo affiliate this year, Martinez slashed .260/.343/.523 while playing both second and third base.

Now, Martinez’s big league career is on hold just days after it first began. The earliest he’ll be able to return to play in the big leagues is September 23 against the Red Sox, although given the fact that Martinez would be ineligible to participate in the postseason due to his suspension and that date landing just six games before the end of the regular season, it wouldn’t be a surprise if Martinez did not end up returning to the majors until the 2025 campaign.

Fortunately for the Blue Jays, the club has plenty of options at its disposal to fill out the club’s infield mix while Bichette is injured, even without Martinez. Isiah Kiner-Falefa has stepped into the everyday role at shortstop since Bichette hit the shelf last week, and the club figures to mix and match between Davis Schneider, Ernie Clement, Addison Barger, and Spencer Horwitz at second and third base while Bichette is away. The addition of Berroa to the roster mix should allow Schneider to mix into the infield more frequently than he has in recent weeks, as he’s split time between the keystone and left field to this point in the season.

As for Berroa, the 25-year-old made his pro debut with the Jays back in 2017 and has worked his way through the club’s minor league system since then, ultimately reaching Triple-A late last year. He struggled in that initial cup of coffee but has hit fairly well in 62 games at the highest level of the minors this season with a .295/.380/.451 slash line across 222 trips to the plate. Berroa figures to factor into the club’s outfield mix behind regulars Daulton Varsho, Kevin Kiermaier, and George Springer alongside Schneider.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top